NCT02279940View on ClinicalTrials.gov

Rivaroxaban Acute Stroke Safety Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2016

Conditions
Acute Ischemic StrokeTransient Ischemic Attack
Trial Locations (1)

T6G 2B7

University of Alberta, Edmonton

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

University of Alberta

OTHER